{"id":67996,"date":"2026-10-27T07:47:55","date_gmt":"2026-10-27T02:17:55","guid":{"rendered":"https:\/\/johnsonfrancis.org\/professional\/?p=67996"},"modified":"2026-10-27T08:21:51","modified_gmt":"2026-10-27T02:51:51","slug":"new-series-of-interactive-cardiology-mcqs-16","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/","title":{"rendered":"New Series of Interactive Cardiology MCQs 16"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><\/p>\n\n\n\n<!-- Cardiology MCQs Part 16 (Full 25 Questions) - WordPress Safe Custom HTML Block -->\n<script src=\"https:\/\/cdn.tailwindcss.com?plugins=forms,typography,aspect-ratio\"><\/script>\n<script>\n  tailwind.config = {\n    corePlugins: { preflight: false }\n  }\n<\/script>\n\n<div id=\"mcq16-quiz-wrapper\" class=\"font-sans bg-slate-950 text-slate-100 p-4 md:p-8 rounded-3xl max-w-4xl mx-auto shadow-2xl relative overflow-hidden my-8 border border-solid border-rose-500\/20\" style=\"box-sizing: border-box;\">\n  \n  <!-- Background Accents -->\n  <div class=\"absolute top-0 left-0 w-full h-full pointer-events-none opacity-10 bg-[radial-gradient(ellipse_at_center,_var(--tw-gradient-stops))] from-rose-500 via-fuchsia-900 to-slate-950\"><\/div>\n  \n  <!-- Header Banner -->\n  <div class=\"relative text-center pb-6 border-b border-solid border-rose-500\/25 mb-8\">\n    <div class=\"inline-block bg-gradient-to-r from-orange-500 via-rose-600 to-fuchsia-600 text-white font-black text-xs md:text-sm px-4 py-1.5 rounded-full uppercase tracking-wider shadow-lg mb-3 animate-pulse\">\n      \u2764\ufe0f Advanced Cardiology Series &#8211; Part 16\n    <\/div>\n    <h1 class=\"text-3xl md:text-5xl font-extrabold tracking-tight text-transparent bg-clip-text bg-gradient-to-r from-orange-300 via-rose-400 to-pink-400 m-0\">\n      Interactive Cardiology MCQs #16\n    <\/h1>\n    <p class=\"text-sm md:text-lg text-slate-300 mt-2 max-w-2xl mx-auto font-medium\">\n      Post-Graduate Level Clinical, Imaging &#038; Pharmacology Masterclass\n    <\/p>\n  <\/div>\n\n  <!-- Real-Time Floating Scoreboard -->\n  <div class=\"sticky top-4 z-40 bg-slate-900\/90 backdrop-blur-md border-2 border-solid border-rose-500\/40 rounded-2xl p-4 mb-8 shadow-xl flex flex-wrap items-center justify-between gap-4\">\n    <div class=\"flex items-center gap-3\">\n      <div class=\"text-3xl\">\ud83c\udfc6<\/div>\n      <div>\n        <div class=\"text-[10px] uppercase font-extrabold tracking-widest text-rose-300\">Live Scoreboard<\/div>\n        <div class=\"text-lg md:text-2xl font-black text-orange-300 flex items-center gap-1\">\n          <span id=\"mcq16-correct-count\">0<\/span><span class=\"text-slate-500 text-sm md:text-lg\">\/ 25 Correct<\/span>\n        <\/div>\n      <\/div>\n    <\/div>\n    <div class=\"flex items-center gap-2 bg-slate-950\/80 px-4 py-2 rounded-xl border border-solid border-slate-800\">\n      <span class=\"text-xs font-bold text-slate-400 uppercase tracking-wider\">Progress:<\/span>\n      <div class=\"w-24 md:w-36 bg-slate-800 h-3 rounded-full overflow-hidden\">\n        <div id=\"mcq16-progress-bar\" class=\"bg-gradient-to-r from-rose-500 to-orange-400 h-full w-0 transition-all duration-300 rounded-full\"><\/div>\n      <\/div>\n      <span class=\"text-xs font-bold text-orange-300\"><span id=\"mcq16-answered-count\">0<\/span>\/25<\/span>\n    <\/div>\n  <\/div>\n\n  <!-- Quiz Questions Container -->\n  <div class=\"space-y-8 relative\">\n\n    <!-- Q1 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q1<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During simultaneous right and left heart catheterization to differentiate constrictive pericarditis from restrictive cardiomyopathy, what respiratory variation in ventricular pressures is the hallmark of constrictive pericarditis?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Concordance (both pressures rising and falling together with respiration) is the hallmark of restrictive cardiomyopathy, where the rigid myocardium dictates filling independent of intrathoracic pressure transfer.\">A) Respiratory concordance of left and right ventricular systolic pressures.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Ventricular interdependence is the physiologic hallmark of constrictive pericarditis. During inspiration, RV filling increases at the expense of the LV (RV systolic pressure rises, LV systolic pressure falls), creating respiratory discordance due to the fixed total cardiac volume mandated by the rigid pericardium.\">B) Respiratory discordance of left and right ventricular systolic pressures (ventricular interdependence).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A 'dip and plateau' (square root sign) occurs in both conditions and is not specific enough to differentiate them independently of respiratory variation.\">C) A prominent &#8216;dip and plateau&#8217; in right ventricular diastolic pressure without any respiratory variation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"While equalization of end-diastolic pressures occurs in both, strict right-sided chamber collapse during inspiration is a sign of tamponade, not constriction.\">D) Complete equalization of end-diastolic pressures with total loss of the y-descent during inspiration.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q2 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q2<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A 40-year-old man with known Brugada syndrome presents to the emergency department. Which of the following acute clinical scenarios is a well-recognized trigger for unmasking the classic Type 1 Brugada ECG pattern and precipitating ventricular fibrillation?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Hypercalcemia shortens the QT interval and is not a classic trigger for Brugada arrhythmias.\">A) Acute hypercalcemia.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Bradycardia, not reflex tachycardia from exercise, is a risk factor. LQT1 is typically triggered by exercise.\">B) Reflex tachycardia during extreme physical exertion.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Fever is a highly documented and significant trigger in Brugada syndrome. Increased body temperature can acutely unmask a Type 1 Brugada ECG pattern (coved ST elevation in V1-V2) and trigger deadly arrhythmias (VF) by further inactivating the mutant sodium channels (SCN5A).\">C) A high fever (e.g., secondary to a viral illness).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Hypoglycemia can prolong the QT interval and trigger arrhythmias in diabetics, but it is not the classic direct trigger for Brugada pattern unmasking.\">D) Severe hypoglycemia.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q3 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q3<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Based on the landmark COAPT trial, which patient profile with severe functional (secondary) mitral regurgitation derives the greatest mortality and heart failure hospitalization benefit from Transcatheter Edge-to-Edge Repair (TEER \/ MitraClip)?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Patients with severely dilated left ventricles (LVEDD > 70 mm) showed no benefit in the COAPT trial and more closely resemble the negative MITRA-FR trial population.&#8221;>A) A patient with extreme left ventricular dilation (LVEDD > 70 mm) and LVEF < 20%.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The COAPT trial demonstrated that TEER benefits patients with 'disproportionate' severe MR: those who have severe MR (Effective Regurgitant Orifice Area >= 0.3 cm2) but with left ventricles that are not yet excessively dilated (LVEDD <= 70 mm) and an LVEF of 20-50%, while on maximally tolerated GDMT.\">B) A patient with severe MR, an LVEF of 20-50%, and an LV end-diastolic dimension (LVEDD) <= 70 mm on optimal GDMT.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Patients requiring right-sided mechanical support or in profound cardiogenic shock were excluded from the COAPT trial.\">C) A patient in unremitting cardiogenic shock requiring an intra-aortic balloon pump.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Patients with preserved LVEF and primary (degenerative) MR undergo surgery or TEER based on surgical risk, but COAPT specifically addressed HFrEF patients with secondary MR.\">D) A patient with preserved LVEF (65%) and primary myxomatous degenerative MR.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q4 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q4<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient undergoes a Cardiac MRI to evaluate left ventricular hypertrophy. The T1 mapping sequence reveals a significantly <em>lowered<\/em> native T1 relaxation time. Which restrictive\/infiltrative cardiomyopathy is characteristically associated with this specific finding?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Cardiac amyloidosis dramatically increases the extracellular volume, leading to markedly ELEVATED native T1 times.\">A) Cardiac Amyloidosis (ATTR or AL)<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Fabry disease (an X-linked lysosomal storage disorder caused by alpha-galactosidase A deficiency) results in the intracellular accumulation of sphingolipids. Lipid accumulation characteristically LOWERS native T1 relaxation times on CMR, distinguishing it from amyloidosis (elevated T1).\">B) Anderson-Fabry Disease<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Cardiac sarcoidosis typically presents with focal patchy LGE and elevated T1\/T2 in areas of active inflammation\/edema.\">C) Cardiac Sarcoidosis<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Hemochromatosis causes iron overload, which profoundly lowers T2* relaxation time, but T1 mapping is not the primary diagnostic sequence for iron.\">D) Hemochromatosis<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q5 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q5<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Vericiguat has been approved for high-risk patients with Heart Failure with Reduced Ejection Fraction (HFrEF) following a worsening heart failure event. What is its precise mechanism of action?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes omecamtiv mecarbil (a cardiac myosin activator), not vericiguat.\">A) It is a direct cardiac myosin activator that prolongs the duration of systole.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes the mechanism of ARNI (sacubitril), which inhibits neprilysin.\">B) It inhibits neprilysin, thereby preventing the degradation of natriuretic peptides.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Vericiguat is a direct stimulator of soluble guanylate cyclase (sGC). It enhances the production of cyclic GMP (cGMP) independently of nitric oxide (NO) availability, restoring the NO-sGC-cGMP pathway which is severely blunted in heart failure, leading to vasodilation and anti-remodeling effects.\">C) It directly stimulates soluble guanylate cyclase (sGC), enhancing cGMP production independently of nitric oxide.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes ivabradine, which acts on the SA node.\">D) It selectively inhibits the If &#8216;funny&#8217; current in the sinoatrial node.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q6 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q6<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In adult congenital heart disease, Ebstein&#8217;s anomaly of the tricuspid valve is highly associated with which specific electrophysiologic condition?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"AVNRT is common in the general population but does not have a specific strong anatomic correlation with Ebstein's anomaly.\">A) Atrioventricular Nodal Reentrant Tachycardia (AVNRT)<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Ebstein's anomaly features apical displacement of the tricuspid valve leaflets and 'atrialization' of the RV. It is strongly associated with the presence of multiple right-sided accessory pathways (Wolff-Parkinson-White syndrome), leading to pre-excitation and AVRT.\">B) Wolff-Parkinson-White (WPW) Syndrome with right-sided accessory pathways<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Fascicular VT is typically idiopathic (in normal structural hearts) and not associated with Ebstein's anomaly.\">C) Left Posterior Fascicular Ventricular Tachycardia<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Brugada syndrome is a channelopathy (SCN5A) without gross structural congenital heart defects like Ebstein's.\">D) Brugada Syndrome Type 1<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q7 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q7<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In evaluating a patient with severe aortic stenosis, the concept of &#8220;paradoxical low-flow, low-gradient&#8221; aortic stenosis refers to a clinical state with a preserved Ejection Fraction (>= 50%). By definition, what stroke volume index (SVi) cut-off defines the &#8220;low-flow&#8221; state in this pathology?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This cut-off is too high.\">A) SVi < 45 mL\/m\u00b2<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This cut-off is incorrectly high for defining low flow.\">B) SVi < 40 mL\/m\u00b2<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"In paradoxical low-flow, low-gradient severe AS, despite a normal LVEF, a hypertrophied, small LV cavity restricts diastolic filling. This results in a 'low-flow' state defined strictly as a Stroke Volume Index (SVi) <= 35 mL\/m\u00b2, which generates a falsely low mean gradient (< 40 mmHg) despite a severe valve area (< 1.0 cm\u00b2).\">C) SVi <= 35 mL\/m\u00b2<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"While SVi < 25 indicates cardiogenic shock or profound output failure, the specific diagnostic cut-off for low-flow AS is 35.\">D) SVi < 25 mL\/m\u00b2<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q8 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q8<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A neonate is born with complete congenital heart block (CHB). Which maternal autoantibodies are most directly implicated in crossing the placenta and destroying the fetal atrioventricular node?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Anti-dsDNA is specific for Systemic Lupus Erythematosus (SLE) nephritis, but not the primary cause of neonatal heart block.\">A) Anti-dsDNA and Anti-Smith antibodies<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Congenital heart block is strongly associated with maternal autoimmune diseases, particularly Sj\u00f6gren's syndrome or SLE. Anti-Ro (SSA) and Anti-La (SSB) IgG antibodies cross the placenta and cause immune-mediated inflammation and irreversible fibrosis of the fetal AV node.\">B) Anti-Ro (SSA) and Anti-La (SSB) antibodies<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Anti-centromere antibodies are associated with CREST syndrome \/ limited scleroderma (and pulmonary hypertension), not fetal AV node destruction.\">C) Anti-centromere antibodies<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Anti-Jo-1 antibodies are associated with polymyositis\/dermatomyositis.\">D) Anti-Jo-1 antibodies<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q9 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q9<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          When applying the Brugada criteria to an ECG showing a wide-complex tachycardia, which is the very first step in determining if the rhythm is Ventricular Tachycardia (VT)?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"AV dissociation is step 3 of the Brugada algorithm.\">A) Looking for signs of atrioventricular (AV) dissociation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Morphology criteria in V1-V2 and V6 are the final step (Step 4) of the algorithm.\">B) Assessing morphology criteria for RBBB or LBBB in leads V1 and V6.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Step 1 of the Brugada algorithm is to evaluate the precordial leads (V1-V6) for the absence of an RS complex (i.e., completely positive or completely negative concordance). If there are NO RS complexes in all precordial leads, the rhythm is definitively VT.\">C) Checking for the absence of an RS complex in all precordial leads (V1-V6).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The RS interval duration (> 100 ms) is step 2 of the algorithm.&#8221;>D) Measuring the R to nadir S interval to see if it is > 100 ms.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q10 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q10<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In patients with severe Carcinoid Heart Disease, which combination of valvular pathologies is most classically observed on echocardiography?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Left-sided valves are usually spared because vasoactive substances (serotonin) are inactivated by monoamine oxidases in the lungs.\">A) Severe Mitral Stenosis and Aortic Regurgitation<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Carcinoid syndrome releases massive amounts of serotonin, leading to fibrotic plaque deposition predominantly on the right-sided valves (as serotonin is cleared in the lungs before reaching the left heart). This classically results in fixed, thickened, retracted leaflets causing severe Tricuspid Regurgitation and Pulmonary Stenosis (or regurgitation).\">B) Severe Tricuspid Regurgitation and Pulmonary Stenosis<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Tricuspid stenosis can occur but regurgitation is overwhelmingly the primary manifestation due to frozen open leaflets, and aortic involvement is exceedingly rare without a PFO.\">C) Severe Tricuspid Stenosis and Aortic Stenosis<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Mitral valve prolapse is a myxomatous degenerative disease not related to carcinoid serotonin deposition.\">D) Severe Pulmonary Regurgitation and Mitral Valve Prolapse<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q11 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q11<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with a mechanical bileaflet mitral valve presents for a routine checkup. The patient asks if they can switch from Warfarin to a Direct Oral Anticoagulant (DOAC) like rivaroxaban or dabigatran. According to trials (RE-ALIGN, PROACT Xa), what is the guideline recommendation?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"There is no approved 3-month transition. DOACs are permanently contraindicated for mechanical valves.\">A) DOACs are permitted only after the first 3 months post-implantation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"DOACs are absolutely contraindicated in patients with mechanical heart valves. The RE-ALIGN (dabigatran) and PROACT Xa (apixaban) trials were both terminated early due to significantly higher rates of valve thrombosis, stroke, and major bleeding compared to Warfarin.\">B) DOACs are strictly contraindicated; Warfarin remains the only approved oral anticoagulant for mechanical valves.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Apixaban failed in mechanical valves (PROACT Xa trial).\">C) Apixaban is uniquely approved if given with low-dose aspirin, but dabigatran is contraindicated.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Rivaroxaban is not approved for mechanical valves under any circumstances.\">D) DOACs are approved, but only if the patient has a history of Warfarin-induced skin necrosis.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q12 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q12<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          During pre-procedural CT planning for Transcatheter Aortic Valve Replacement (TAVR), which anatomical combination poses the highest risk for acute coronary artery occlusion during valve deployment?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The highest risk of the native valve leaflets being pushed up to block the coronary ostia occurs when the coronary heights are low (< 10-12 mm from the annulus) AND the Sinus of Valsalva is narrow (< 30 mm), leaving no room for the displaced native leaflets.\">A) Low coronary ostia height and a narrow Sinus of Valsalva<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"High coronary ostia lower the risk of obstruction.\">B) High coronary ostia height and a capacious, wide Sinus of Valsalva<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Severe annular calcification increases the risk of paravalvular leak or annular rupture, not primarily coronary obstruction unless associated with bulky leaflet calcium.\">C) Severe calcification of the non-coronary cusp and a wide Sinus of Valsalva<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Bicuspid valves increase the risk of PVL and rupture, but high take-offs protect the coronaries.\">D) A bicuspid aortic valve with very high coronary artery take-offs<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q13 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q13<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In echocardiographic assessment of primary (degenerative) mitral regurgitation, which Vena Contracta width is the established cutoff indicating &#8220;severe&#8221; MR?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"> 0.3 cm characterizes mild MR.&#8221;>A) >= 0.3 cm<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"> 0.5 cm is often considered moderate.&#8221;>B) >= 0.5 cm<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The vena contracta is the narrowest neck of the regurgitant jet. According to ASE guidelines, a vena contracta width of >= 0.7 cm is a specific criteria for severe primary mitral regurgitation.&#8221;>C) >= 0.7 cm<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\">= 1.0 cm is massive\/extreme, but the cutoff for &#8216;severe&#8217; starts at 0.7 cm.&#8221;>D) >= 1.0 cm<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q14 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q14<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Ticagrelor is a potent P2Y12 inhibitor used in acute coronary syndromes. Unlike Clopidogrel or Prasugrel, what is its unique pharmacological property?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Clopidogrel and Prasugrel are prodrugs requiring hepatic activation (CYP enzymes), not Ticagrelor.\">A) It is a prodrug that requires a two-step hepatic activation process via CYP2C19.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Unlike Clopidogrel and Prasugrel (which are thienopyridines that irreversibly bind the receptor for the life of the platelet), Ticagrelor is a cyclopentyltriazolopyrimidine (CPTP). It binds directly (no prodrug activation needed) and REVERSIBLY to the P2Y12 receptor, allowing for faster offset of action when stopped.\">B) It is a direct-acting, reversible inhibitor of the P2Y12 receptor (not a thienopyridine).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes Glycoprotein IIb\/IIIa inhibitors (like eptifibatide or tirofiban).\">C) It directly blocks the Glycoprotein IIb\/IIIa receptor pathway.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Ticagrelor is given orally, not intravenously. (Cangrelor is the IV P2Y12 inhibitor).\">D) It is only available as an intravenous infusion.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q15 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q15<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with an acute inferior STEMI suddenly develops profound hypotension, a loud holosystolic murmur at the apex, and pulmonary edema. Right heart catheterization shows prominent &#8220;v&#8221; waves in the pulmonary capillary wedge pressure (PCWP) tracing. What is the diagnosis?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A VSD causes an oxygen step-up in the right ventricle, and typically presents with a harsh parasternal murmur, not giant 'v' waves in the PCWP.\">A) Post-infarction Ventricular Septal Defect (VSD)<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Acute rupture of the posteromedial papillary muscle (classically caused by an inferior STEMI due to its single blood supply from the PDA) causes acute, massive mitral regurgitation. This massive retrograde flow into the left atrium during systole creates giant 'v' waves on the PCWP tracing.\">B) Acute rupture of the posteromedial papillary muscle<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"RV infarction causes profound hypotension and elevated Right Atrial Pressure, but usually clear lungs and no loud apical holosystolic murmur.\">C) Acute right ventricular infarction<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Free wall rupture leads to acute cardiac tamponade (pulseless electrical activity), without prominent 'v' waves or an apical MR murmur.\">D) Left ventricular free wall rupture<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q16 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q16<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Patients with a bicuspid aortic valve (BAV) have a high incidence of a concurrent congenital vascular anomaly. Which vascular pathology MUST be aggressively screened for in every patient newly diagnosed with a BAV?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"PDA is associated with congenital rubella syndrome and prematurity, not heavily linked to BAV.\">A) Patent Ductus Arteriosus (PDA)<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Intracranial berry aneurysms are associated with adult polycystic kidney disease (ADPKD).\">B) Intracranial berry aneurysms<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Bicuspid aortic valves are a systemic aortopathy, highly associated with dilation\/aneurysm of the ascending aorta (in up to 50% of patients) and Coarctation of the Aorta. The thoracic aorta must be entirely imaged via CT or CMR.\">C) Aneurysm of the ascending aorta and Coarctation of the Aorta<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Anomalous coronary origins from the opposite sinus occur independently of BAV.\">D) Anomalous origin of the left main coronary artery from the right sinus of Valsalva<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q17 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q17<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In patients with severe renal impairment (e.g., GFR < 30) taking Spironolactone for heart failure, the risk of life-threatening hyperkalemia is significant. Which novel class of potassium binders (e.g., Patiromer, SZC) can be utilized to maintain Guideline-Directed Medical Therapy (GDMT)?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Furosemide is a loop diuretic; it wastes potassium but is not a 'potassium binder'.\">A) High-dose loop diuretics (e.g., Furosemide)<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Patiromer and Sodium Zirconium Cyclosilicate (SZC) are novel gastrointestinal potassium-binding polymers. They safely excrete excess potassium in the stool, allowing heart failure patients to remain on life-saving RAAS inhibitors\/MRAs despite underlying chronic kidney disease.\">B) Gastrointestinal potassium-binding polymers<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Calcium gluconate stabilizes the cardiac membrane during acute hyperkalemic emergencies; it does not bind or lower total body potassium.\">C) Intravenous calcium gluconate<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Insulin\/dextrose shifts potassium intracellularly temporarily, but does not excrete it and cannot be used as chronic maintenance therapy.\">D) Oral insulin and dextrose<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q18 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q18<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          A patient with non-valvular atrial fibrillation has a high CHA2DS2-VASc score and recurrent severe GI bleeding, prompting consideration for a Left Atrial Appendage (LAA) closure device (e.g., Watchman). What is an absolute anatomical\/clinical contraindication to placing this device?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A 'Chicken Wing' morphology is one of the standard, acceptable anatomies for device placement.\">A) A &#8216;Chicken Wing&#8217; morphology of the left atrial appendage on TEE.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"A high HAS-BLED score is the precise indication FOR the procedure (to get them off long-term DOACs).\">B) A HAS-BLED score > 3 indicating high baseline bleeding risk.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"The presence of an active, pre-existing thrombus in the LAA is an absolute contraindication to percutaneous device placement, as maneuvering the device risks catastrophic systemic embolization (stroke). The thrombus must be dissolved with prolonged anticoagulation first.\">C) The presence of an active, organized thrombus currently residing in the LAA.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"The procedure requires transseptal puncture; an intact septum is standard and not a contraindication.\">D) An entirely intact interatrial septum without a Patent Foramen Ovale (PFO).<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q19 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q19<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          According to the REDUCE-IT trial, Icosapent ethyl (a highly purified EPA omega-3 fatty acid) is indicated to reduce cardiovascular events in a very specific patient cohort. Which lipid profile parameters identify the appropriate candidate?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Isolated hypercholesterolemia with normal TG is treated with Statins, Ezetimibe, or PCSK9i.\">A) Very high LDL-C (> 190 mg\/dL) with normal Triglycerides (< 150 mg\/dL).<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Icosapent ethyl is indicated for patients with established CVD (or diabetes with >=2 risk factors) who are already on maximally tolerated statin therapy, but persistently have elevated Triglycerides (135-499 mg\/dL).&#8221;>B) Patients on statin therapy with persistently elevated Triglycerides (> 135-150 mg\/dL) and established CVD or diabetes.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"While fibrates might be used for extreme TG > 1000 mg\/dL to prevent pancreatitis, the REDUCE-IT trial specifically targeted moderate hypertriglyceridemia for ASCVD risk reduction.&#8221;>C) Patients strictly with Triglycerides > 1000 mg\/dL to prevent acute pancreatitis, regardless of CVD risk.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Omega-3s do not target isolated low HDL.\">D) Patients with isolated low HDL-C (< 30 mg\/dL) and normal Triglycerides.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q20 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q20<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In a patient with cardiac tamponade, what is the pathophysiologic mechanism behind &#8220;Pulsus Paradoxus&#8221; (an exaggerated drop > 10 mmHg in systolic blood pressure during inspiration)?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Venous return actually increases to the right heart during inspiration.\">A) A dramatic decrease in venous return to the right atrium during inspiration due to elevated intrathoracic pressure.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"During inspiration, negative intrathoracic pressure increases venous return to the RV. Because the pericardium is tense with fluid (fixed total volume), the enlarging RV pushes the interventricular septum to the left. This compresses the LV cavity, reducing LV end-diastolic volume and consequently stroke volume and systolic BP.\">B) Increased right ventricular filling bowing the interventricular septum leftward into the LV cavity, reducing LV stroke volume.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Autonomic reflexes do not cause the acute, breath-by-breath mechanical shift seen in pulsus paradoxus.\">C) Reflex vagal tone triggered by pulmonary stretch receptors during deep inspiration.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Tamponade involves diastolic equalization of pressures, not severe acute MR.\">D) Acute flail of the mitral leaflet due to papillary muscle ischemia during inspiration.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q21 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q21<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          The proteasome inhibitor Carfilzomib, used in the treatment of multiple myeloma, is notoriously associated with which severe cardiovascular toxicity?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Prolonged QT is a hallmark of arsenic trioxide or certain kinase inhibitors.\">A) Profound QT interval prolongation leading to Torsades de Pointes<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Carfilzomib exhibits significant endothelial toxicity. It is highly associated with new-onset, severe, and frequently refractory hypertension, as well as acute heart failure\/pulmonary edema in up to 20% of patients.\">B) Severe hypertension, endothelial dysfunction, and new-onset Heart Failure<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Coronary vasospasm is the hallmark of 5-Fluorouracil (5-FU).\">C) Severe acute coronary vasospasm<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Fulminant myocarditis is a classic toxicity of Immune Checkpoint Inhibitors (e.g., nivolumab).\">D) T-cell mediated autoimmune fulminant myocarditis<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q22 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q22<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          When interpreting the results of an intravascular ultrasound (IVUS) in the Left Main Coronary Artery, what Minimum Lumen Area (MLA) cut-off generally supports the decision to defer percutaneous intervention because the lesion is considered hemodynamically non-significant?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This is the cutoff for non-left main vessels.\">A) MLA >= 4.0 mm\u00b2<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"For the Left Main Coronary Artery, which supplies the vast majority of left ventricular myocardium, the validated safety cut-off for deferring PCI is a Minimum Lumen Area (MLA) >= 6.0 mm\u00b2 on IVUS. (For other non-left main epicardial vessels, the cutoff is typically 4.0 mm\u00b2).&#8221;>B) MLA >= 6.0 mm\u00b2<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This would be considered a severe left main stenosis necessitating revascularization.\">C) MLA >= 2.0 mm\u00b2<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"10.0 mm\u00b2 is completely normal and far above the safety cut-off.\">D) MLA >= 10.0 mm\u00b2<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q23 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q23<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          The presence of &#8220;Kussmaul&#8217;s Sign&#8221; during physical examination (a paradoxical rise in jugular venous pressure during inspiration) is indicative of right heart failure and is classically associated with which condition?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Cardiac tamponade classically LACKS Kussmaul's sign, but presents with Pulsus Paradoxus.\">A) Acute Cardiac Tamponade<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Kussmaul's sign occurs when the right ventricle cannot accommodate the increased venous return during inspiration, causing blood to back up into the jugular veins. It is a classic sign of Constrictive Pericarditis, restrictive cardiomyopathy, and severe RV infarction, but is classically ABSENT in cardiac tamponade.\">B) Constrictive Pericarditis<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Mitral stenosis affects left atrial filling and would not cause an inspiratory rise in JVP directly unless severe secondary RV failure has occurred.\">C) Rheumatic Mitral Stenosis<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Aortic regurgitation predominantly affects the left ventricle and pulse pressure, not right atrial filling dynamics directly.\">D) Acute Aortic Regurgitation<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q24 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q24<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          Mavacamten is a novel, first-in-class therapy FDA-approved for symptomatic Hypertrophic Obstructive Cardiomyopathy (HOCM). What is its specific mechanism of action?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"Mavacamten is an allosteric inhibitor of cardiac myosin ATPase. It specifically reduces the number of actin-myosin cross-bridges that can form during systole, thereby reducing myocardial contractility, decreasing the LV outflow tract gradient, and relieving symptoms in HOCM.\">A) It is a cardiac myosin ATPase inhibitor that reduces actin-myosin cross-bridge formation, reducing excessive contractility.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes omecamtiv mecarbil (a myosin activator for HFrEF).\">B) It is a cardiac myosin activator that increases the duration of systole without increasing oxygen consumption.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes beta-blockers, the older standard of care.\">C) It is a highly selective beta-1 adrenergic receptor antagonist.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This describes ranolazine.\">D) It inhibits the late inward sodium current (INa) to reduce intracellular calcium overload.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n    <!-- Q25 -->\n    <div class=\"quiz-card bg-slate-900\/60 border border-solid border-slate-800 rounded-2xl p-5 md:p-6 shadow-lg transition-all duration-300\" data-answered=\"false\">\n      <div class=\"flex items-start gap-3 mb-4\">\n        <span class=\"bg-rose-950 text-orange-300 font-extrabold px-3 py-1.5 rounded-lg text-sm border border-solid border-rose-500\/30\">Q25<\/span>\n        <h3 class=\"text-lg md:text-xl font-bold text-slate-100 m-0 leading-snug\">\n          In the management of Atrial Fibrillation, the CABANA trial compared catheter ablation to medical therapy. What was the primary conclusion regarding mortality and stroke endpoints?\n        <\/h3>\n      <\/div>\n      <div class=\"grid grid-cols-1 md:grid-cols-2 gap-3 mb-4\">\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Ablation was not vastly superior for the primary hard endpoints, though it improved quality of life.\">A) Catheter ablation was vastly superior to medical therapy, reducing all-cause mortality by over 40%.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"true\" data-explanation=\"In the intention-to-treat analysis, the CABANA trial showed no statistically significant difference in the primary composite endpoint of death, disabling stroke, serious bleeding, or cardiac arrest between ablation and medical therapy. However, ablation significantly improved quality of life and freedom from AFib recurrence.\">B) There was no statistically significant difference in the primary composite endpoint of death, stroke, bleeding, or cardiac arrest between the two groups.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"Medical therapy did not significantly reduce strokes compared to ablation.\">C) Medical therapy significantly reduced the rate of disabling stroke compared to catheter ablation.<\/button>\n        <button type=\"button\" class=\"opt-btn text-left p-4 rounded-xl border-2 border-solid border-slate-800 bg-slate-950 hover:bg-slate-900 transition-all text-sm md:text-base font-semibold text-slate-300 cursor-pointer\" data-correct=\"false\" data-explanation=\"This conclusion was drawn from the AFFIRM trial regarding rate vs rhythm control, not the CABANA trial.\">D) Catheter ablation actually increased mortality due to procedural complications, favoring rate control.<\/button>\n      <\/div>\n      <div class=\"feedback-box hidden p-4 rounded-xl text-sm md:text-base leading-relaxed\"><\/div>\n    <\/div>\n\n  <\/div>\n<\/div>\n\n<script>\n  let mcq16Correct = 0;\n  let mcq16Answered = 0;\n  const mcq16Total = 25;\n\n  document.querySelectorAll('#mcq16-quiz-wrapper .quiz-card').forEach(card => {\n    const buttons = card.querySelectorAll('.opt-btn');\n    buttons.forEach(btn => {\n      btn.addEventListener('click', function() {\n        if (card.getAttribute('data-answered') === 'true') return;\n        card.setAttribute('data-answered', 'true');\n        mcq16Answered++;\n\n        document.getElementById('mcq16-answered-count').innerText = mcq16Answered;\n        const pct = (mcq16Answered \/ mcq16Total) * 100;\n        document.getElementById('mcq16-progress-bar').style.width = pct + '%';\n\n        buttons.forEach(b => {\n          b.disabled = true;\n          b.classList.remove('hover:bg-slate-900', 'cursor-pointer');\n          b.classList.add('opacity-50', 'cursor-not-allowed');\n        });\n\n        const isCorrect = this.getAttribute('data-correct') === 'true';\n        const explanation = this.getAttribute('data-explanation');\n\n        if (isCorrect) {\n          mcq16Correct++;\n          document.getElementById('mcq16-correct-count').innerText = mcq16Correct;\n          this.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n          this.classList.add('bg-emerald-950\/80', 'border-emerald-500', 'text-emerald-200', 'opacity-100', 'border-2');\n          this.innerHTML += ' <span class=\"font-bold\">&#10004; CORRECT!<\/span>';\n        } else {\n          this.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n          this.classList.add('bg-red-950\/80', 'border-red-500', 'text-red-200', 'opacity-100', 'border-2');\n          this.innerHTML += ' <span class=\"font-bold\">&#10006; INCORRECT<\/span>';\n\n          buttons.forEach(b => {\n            if (b.getAttribute('data-correct') === 'true') {\n              b.classList.remove('opacity-50', 'border-slate-800', 'bg-slate-950');\n              b.classList.add('bg-emerald-950\/40', 'border-emerald-500\/55', 'text-emerald-200', 'opacity-100', 'border-2');\n              b.innerHTML += ' <span class=\"font-bold\">&#10004; (Correct)<\/span>';\n            }\n          });\n        }\n\n        const feedback = card.querySelector('.feedback-box');\n        feedback.innerHTML = `\n          <div class=\"font-extrabold uppercase tracking-widest text-xs mb-2 ${isCorrect ? 'text-emerald-400' : 'text-red-400'}\">\n            ${isCorrect ? 'Clinical Explanation' : 'Explanation & Correct Answer'}\n          <\/div>\n          <p class=\"m-0\">${explanation}<\/p>\n        `;\n        feedback.classList.remove('hidden');\n        feedback.classList.add('block', isCorrect ? 'bg-emerald-950\/45' : 'bg-red-950\/20', 'border-2', 'border-solid', isCorrect ? 'border-emerald-500\/30' : 'border-red-500\/30', 'text-slate-200', 'mt-4');\n      });\n    });\n  });\n<\/script>\n","protected":false},"excerpt":{"rendered":"<p>\u2764\ufe0f Advanced Cardiology Series &#8211; Part 16 Interactive Cardiology MCQs #16 Post-Graduate Level Clinical, Imaging &#038; Pharmacology Masterclass \ud83c\udfc6 Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 During simultaneous right and left heart catheterization to differentiate constrictive pericarditis from restrictive cardiomyopathy, what respiratory variation in ventricular pressures is the hallmark of constrictive pericarditis? A) Respiratory [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":67998,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-67996","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>New Series of Interactive Cardiology MCQs 16 - All About Cardiovascular System and Disorders<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"New Series of Interactive Cardiology MCQs 16 - All About Cardiovascular System and Disorders\" \/>\n<meta property=\"og:description\" content=\"\u2764\ufe0f Advanced Cardiology Series &#8211; Part 16 Interactive Cardiology MCQs #16 Post-Graduate Level Clinical, Imaging &#038; Pharmacology Masterclass \ud83c\udfc6 Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 During simultaneous right and left heart catheterization to differentiate constrictive pericarditis from restrictive cardiomyopathy, what respiratory variation in ventricular pressures is the hallmark of constrictive pericarditis? A) Respiratory [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Cardiovascular System and Disorders\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-27T02:17:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-10-27T02:51:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-16.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1208\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"9 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-16\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-16\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"headline\":\"New Series of Interactive Cardiology MCQs 16\",\"datePublished\":\"2026-10-27T02:17:55+00:00\",\"dateModified\":\"2026-10-27T02:51:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-16\\\/\"},\"wordCount\":221,\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-16\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-16.jpg\",\"articleSection\":[\"General Cardiology\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-16\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-16\\\/\",\"name\":\"New Series of Interactive Cardiology MCQs 16 - All About Cardiovascular System and Disorders\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-16\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-16\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-16.jpg\",\"datePublished\":\"2026-10-27T02:17:55+00:00\",\"dateModified\":\"2026-10-27T02:51:51+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-16\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-16\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-16\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-16.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/New-Series-of-Interactive-Cardiology-MCQs-16.jpg\",\"width\":1208,\"height\":675},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/new-series-of-interactive-cardiology-mcqs-16\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"New Series of Interactive Cardiology MCQs 16\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/\",\"name\":\"All About Cardiovascular System and Disorders\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":[\"Person\",\"Organization\"],\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/#\\\/schema\\\/person\\\/5441d907049b914770f4bd98fb57feec\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"logo\":{\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/professional\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"New Series of Interactive Cardiology MCQs 16 - All About Cardiovascular System and Disorders","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/","og_locale":"en_US","og_type":"article","og_title":"New Series of Interactive Cardiology MCQs 16 - All About Cardiovascular System and Disorders","og_description":"\u2764\ufe0f Advanced Cardiology Series &#8211; Part 16 Interactive Cardiology MCQs #16 Post-Graduate Level Clinical, Imaging &#038; Pharmacology Masterclass \ud83c\udfc6 Live Scoreboard 0\/ 25 Correct Progress: 0\/25 Q1 During simultaneous right and left heart catheterization to differentiate constrictive pericarditis from restrictive cardiomyopathy, what respiratory variation in ventricular pressures is the hallmark of constrictive pericarditis? A) Respiratory [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/","og_site_name":"All About Cardiovascular System and Disorders","article_published_time":"2026-10-27T02:17:55+00:00","article_modified_time":"2026-10-27T02:51:51+00:00","og_image":[{"width":1208,"height":675,"url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-16.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"9 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"headline":"New Series of Interactive Cardiology MCQs 16","datePublished":"2026-10-27T02:17:55+00:00","dateModified":"2026-10-27T02:51:51+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/"},"wordCount":221,"publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-16.jpg","articleSection":["General Cardiology"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/","url":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/","name":"New Series of Interactive Cardiology MCQs 16 - All About Cardiovascular System and Disorders","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-16.jpg","datePublished":"2026-10-27T02:17:55+00:00","dateModified":"2026-10-27T02:51:51+00:00","breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-16.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/professional\/wp-content\/uploads\/2026\/10\/New-Series-of-Interactive-Cardiology-MCQs-16.jpg","width":1208,"height":675},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/professional\/new-series-of-interactive-cardiology-mcqs-16\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/professional\/"},{"@type":"ListItem","position":2,"name":"New Series of Interactive Cardiology MCQs 16"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/professional\/#website","url":"https:\/\/johnsonfrancis.org\/professional\/","name":"All About Cardiovascular System and Disorders","description":"","publisher":{"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/professional\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":["Person","Organization"],"@id":"https:\/\/johnsonfrancis.org\/professional\/#\/schema\/person\/5441d907049b914770f4bd98fb57feec","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"logo":{"@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/professional\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67996","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/comments?post=67996"}],"version-history":[{"count":2,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67996\/revisions"}],"predecessor-version":[{"id":67999,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/posts\/67996\/revisions\/67999"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media\/67998"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/media?parent=67996"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/categories?post=67996"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/professional\/wp-json\/wp\/v2\/tags?post=67996"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}